Search This Blog

Monday, August 5, 2019

ChemoCentryx, Inc. EPS misses by $0.04, misses on revenue

ChemoCentryx, Inc. (NASDAQ:CCXI): Q2 GAAP EPS of -$0.26 misses by $0.04.
Revenue of $7.17M (-52.3% Y/Y) misses by $2.66M.
Shares -2.76%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)